melanotan side effects 2016 Afamelanotide tested as a new treatment for vitiligo – Vitiligo Clinic Evaluation of synthetic alpha-melanocyte-stimulating hormone
Description
Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study
Dent Clin North Am 2005;49:185-201
doi: 10.1002/rcm.1290070508
[DOI] [PubMed] [Google Scholar] 426.Najat Nakishbandy B.M., Barawi S.A.M
